Published in J Clin Invest on March 01, 2000
G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther (2011) 2.13
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut (2002) 1.82
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31
Chronic intermittent hypoxia induces NMDA receptor-dependent plasticity and suppresses nitric oxide signaling in the mouse hypothalamic paraventricular nucleus. J Neurosci (2010) 1.08
Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats. BMC Gastroenterol (2003) 1.08
Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol (2014) 1.04
Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol (2013) 0.92
Stellate cell contraction: role, regulation, and potential therapeutic target. Clin Liver Dis (2008) 0.91
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol (2015) 0.90
In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats. Gut (2002) 0.90
Divergent transforming growth factor-beta signaling in hepatic stellate cells after liver injury: functional effects on ECE-1 regulation. Am J Pathol (2008) 0.88
Fibronectin stimulates endothelin-1 synthesis in rat hepatic myofibroblasts via a Src/ERK-regulated signaling pathway. Gastroenterology (2009) 0.85
Efficient hepatic delivery of drugs: novel strategies and their significance. Biomed Res Int (2013) 0.85
Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts. BMC Cell Biol (2000) 0.84
Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver. BMC Gastroenterol (2009) 0.80
Pathophysiology of portal hypertension and its clinical links. J Clin Exp Hepatol (2011) 0.79
Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World J Gastroenterol (2006) 0.79
Research progress of vasculopathy in portal hypertension. World J Gastroenterol (2005) 0.78
Integrin-linked kinase regulates endothelial cell nitric oxide synthase expression in hepatic sinusoidal endothelial cells. Liver Int (2014) 0.76
Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension. World J Hepatol (2017) 0.75
The Molecular Basis of Portal Hypertension. Trans Am Clin Climatol Assoc (2017) 0.75
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med (1993) 5.97
Nitric oxide synthases: which, where, how, and why? J Clin Invest (1997) 3.81
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest (1998) 3.71
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem (1987) 2.31
Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology (1998) 2.18
Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology (1984) 2.14
Parenchymal cells from adult rat liver in nonproliferating monolayer culture. I. Functional studies. J Cell Biol (1973) 2.09
High yield micronodular cirrhosis in the rat. Gastroenterology (1982) 1.97
The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem (1998) 1.91
The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol (1997) 1.89
The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol (1993) 1.88
Characterization and culture of sinusoidal endothelium from normal rat liver: lipoprotein uptake and collagen phenotype. Gastroenterology (1984) 1.78
Endothelial dysfunction in human disease. J Mol Cell Cardiol (1999) 1.77
Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology (1998) 1.68
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology (1996) 1.66
Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest (1993) 1.63
Adenoviral vectors for gene transfer. Curr Opin Biotechnol (1997) 1.60
Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology (1999) 1.58
Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol (1999) 1.47
Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology (1998) 1.47
Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol (1994) 1.44
Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest (1995) 1.41
The endothelin system. A new target for therapeutic intervention. Circulation (1994) 1.30
Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology (1998) 1.21
Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest (1997) 1.20
Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry (1998) 1.18
Secondary endothelial dysfunction: hypertension and heart failure. J Mol Cell Cardiol (1999) 1.06
Phenotypic modulation in lipocytes in experimental liver fibrosis. J Pathol (1991) 1.04
Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis. Am J Physiol (1997) 0.99
ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action. Am J Physiol (1994) 0.99
Adenovirus-mediated expression of cytokine-induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis. Hepatology (1997) 0.99
The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference. Neuroreport (1998) 0.96
Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci (1996) 0.95
Targeting nitric oxide to its targets. Proc Soc Exp Biol Med (1996) 0.93
Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res (1996) 0.92
Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology (1994) 0.91
The hepatic circulation in health and disease: report of a single-topic symposium. Hepatology (1998) 0.90
A time-dependent balance between endothelins and nitric oxide regulating portal resistance after endotoxin. Am J Physiol (1996) 0.87
Isosorbide dinitrate in experimental portal hypertension: a study of factors that modulate the hemodynamic response. Hepatology (1986) 0.85
Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat. Hepatology (1995) 0.84
Hepatic oleate uptake. Electrochemical driving forces in intact rat liver. J Clin Invest (1989) 0.81
Localization of neuronal nitric oxide synthase. Methods Enzymol (1996) 0.79
Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med (2000) 2.40
Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology (1992) 2.40
An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res (2000) 2.36
Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol (1994) 2.18
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine (Baltimore) (1996) 2.17
Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A (1997) 2.03
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci U S A (1998) 1.93
Gastroesophageal variceal hemorrhage. N Engl J Med (2001) 1.90
Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease. Am J Med (1996) 1.64
The ephrin VAB-2/EFN-1 functions in neuronal signaling to regulate epidermal morphogenesis in C. elegans. Cell (1999) 1.47
Endoscopic therapy of acute diverticular hemorrhage. Am J Gastroenterol (2001) 1.45
The physician-scientist template. Science (1999) 1.40
The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med (2000) 1.39
Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci U S A (1993) 1.38
Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation (1999) 1.35
Diauxic growth in Azotobacter vinelandii. J Bacteriol (1985) 1.35
Amebic liver abscess: epidemiology, clinical features, and outcome. West J Med (1999) 1.30
The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem (1997) 1.29
Extraordinary number of gene rearrangements in the mitochondrial genomes of lice (Phthiraptera: Insecta). Insect Mol Biol (2006) 1.18
Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. Circ Res (1998) 1.16
Provocative angiography in patients with gastrointestinal hemorrhage of obscure origin. Am J Gastroenterol (2000) 1.15
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol (2000) 1.13
Increased rate of gene rearrangement in the mitochondrial genomes of three orders of hemipteroid insects. Mol Biol Evol (2001) 1.12
Expression of the integrin alpha8beta1 during pulmonary and hepatic fibrosis. Am J Pathol (2000) 1.10
Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther (2003) 1.09
Role of the gastrointestinal mucosa and microflora in the bioactivation of dietary and environmental mutagens or carcinogens. Drug Metab Rev (1992) 1.07
Differential gene expression identified in Uigur women cervical squamous cell carcinoma by suppression subtractive hybridization. Neoplasma (2010) 1.05
Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice. Gene Ther (2007) 1.05
Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev (2003) 1.04
Duodenal somatostatinoma presenting with complete somatostatinoma syndrome. J Clin Gastroenterol (2001) 1.04
Comparison of patients' experiences during imaging tests of the colon. Gastrointest Endosc (2001) 1.03
p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis. Oncogene (2001) 1.01
Hepatic lipocytes: a major target for endothelin-1. J Hepatol (1995) 1.01
E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway. Clin Cancer Res (2000) 0.98
Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production. Circulation (2001) 0.97
The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer. Oncogene (1997) 0.96
Progesterone receptor antagonists Org 31710 and RU 486 increase apoptosis in human periovulatory granulosa cells. Fertil Steril (2001) 0.95
Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol (2000) 0.95
In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-Fed rabbits. Circulation (1998) 0.94
Management of gastric varices. Gastroenterology (2001) 0.93
The calmodulin-nitric oxide synthase interaction. Critical role of the calmodulin latch domain in enzyme activation. J Biol Chem (1995) 0.93
Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection. J Viral Hepat (2006) 0.93
Mutagenicity of HPLC-fractionated urinary metabolites from 2,4,6-trinitrotoluene-treated Fischer 344 rats. Environ Mol Mutagen (1997) 0.92
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Mol Genet Metab (2013) 0.92
In vitro methylation of inorganic arsenic in mouse intestinal cecum. Toxicol Appl Pharmacol (1997) 0.92
Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev (2001) 0.92
Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res (1996) 0.92
Neuronal nitric-oxide synthase interaction with calmodulin-troponin C chimeras. J Biol Chem (1998) 0.92
Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy. Arterioscler Thromb Vasc Biol (2000) 0.91
Inferior vena cava plethora with blunted respiratory response: a sensitive echocardiographic sign of cardiac tamponade. J Am Coll Cardiol (1988) 0.90
Calmodulin activation of target enzymes. Consequences of deletions in the central helix. J Biol Chem (1990) 0.88
X-ray analysis reveals conformational adaptation of the linker in functional calmodulin mutants. Nat Struct Biol (1995) 0.87
Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy. Gastroenterology (2000) 0.87
Cytomegalovirus colitis presenting with the endoscopic appearance of pseudomembranous colitis. Gastrointest Endosc (1999) 0.87
Structural determinants of Ca2+ exchange and affinity in the C terminal of cardiac troponin C. Biochemistry (1998) 0.87
The outpatient evaluation of hematochezia. Am J Gastroenterol (1998) 0.86
Regulation of endothelin-1 synthesis by endothelin-converting enzyme-1 during wound healing. J Biol Chem (1999) 0.86
p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models. Cancer Res (2001) 0.86
Interleukin-6 receptor α is co-localised with melanin-concentrating hormone in human and mouse hypothalamus. J Neuroendocrinol (2012) 0.86
Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis. Aliment Pharmacol Ther (2009) 0.85
Activation of rat hepatic stellate cells leads to loss of glutathione S-transferases and their enzymatic activity against products of oxidative stress. Hepatology (1999) 0.85
Role of domain 3 of calmodulin in activation of calmodulin-stimulated phosphodiesterase and smooth muscle myosin light chain kinase. J Biol Chem (1994) 0.83
Selective activation and inhibition of calmodulin-dependent enzymes by a calmodulin-like protein found in human epithelial cells. Eur J Biochem (1994) 0.82
p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasia. Mol Ther (2001) 0.82
Cloning and molecular characterization of csm mutations allowing expression of catabolite-repressible operons in the absence of exogenous cyclic AMP. J Bacteriol (1986) 0.81
Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats. Hepatology (1998) 0.80
Crystallization and preliminary X-ray crystallographic studies of a macromolecular antitumour antibiotic, C1027. Acta Crystallogr D Biol Crystallogr (2001) 0.80
Collagen-homology domain 1 deletion mutant of Shc suppresses transformation mediated by neu through a MAPK-independent pathway. Oncogene (1999) 0.79
Identification and characterization of a truncated variant of the 5-hydroxytryptamine(2A) receptor produced by alternative splicing. Brain Res (2000) 0.79
Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score. Am J Gastroenterol (1998) 0.79
Improved adenoviral vectors: cautious optimism for gene therapy. QJM (1997) 0.79
The role of endothelial nitric oxide synthase expression in the development of pulmonary hypertension in chronically hypoxic infant swine. J Thorac Cardiovasc Surg (1998) 0.79
Metabolism, microflora effects, and genotoxicity in haloacetic acid-treated cultures of rat cecal microbiota. Toxicol Sci (2001) 0.79
Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation. Circ Res (2001) 0.79
Partial agonism at serotonin 5-HT1B and dopamine D2L receptors using a luciferase reporter gene assay. Eur J Pharmacol (1999) 0.78
Impacts of aging on in vivo and in vitro measurements of soil-bound polycyclic aromatic hydrocarbon availability. Environ Sci Technol (2001) 0.78
Potentiation of 2,6-dinitrotoluene genotoxicity in Fischer 344 rats by pretreatment with coal tar creosote. J Toxicol Environ Health (1995) 0.78
Provocative angiography in obscure gastrointestinal bleeding. South Med J (2000) 0.77
Calmodulin is intrinsically LESS effective than troponin C in activating skeletal muscle contraction. FEBS Lett (1994) 0.77
Preliminary evaluation of 15-[18F]fluoro-3-oxa-pentadecanoate as a PET tracer of hepatic fatty acid oxidation. J Nucl Med (2000) 0.77
Bioavailability of the genotoxic components in coal tar contaminated soils in Fischer 344 rats. Toxicol Sci (2000) 0.77
Possible errors in assay for beta-glycosidase activity. Appl Environ Microbiol (1995) 0.76
Diet-induced protection against lipopolysaccharide includes increased hepatic NO production. J Surg Res (1999) 0.76
Second-generation sequencing of entire mitochondrial coding-regions (∼15.4 kb) holds promise for study of the phylogeny and taxonomy of human body lice and head lice. Med Vet Entomol (2014) 0.76
Gastrointestinal evaluation for premenopausal women with iron deficiency anemia: what is appropriate? Am J Med (1998) 0.76
Relationship of low-dose aspirin to GI injury and occult bleeding: a pilot study. Gastrointest Endosc (1999) 0.76
Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels. Cardiovasc Res (1997) 0.76
Utility of 'liver function tests' in alcoholic patients. West J Med (1992) 0.75
Ultrasonography or venography for the diagnosis of TIPS malfunction? Gastroenterology (1998) 0.75
Gastroenterologists of the new millennium. Gastroenterology (1999) 0.75
Vascular gene transfer. Heart (1996) 0.75
Isolation and characterization of an attenuated strain of Pseudomonas aeruginosa AC869, a 3,5-dichlorobenzoate degrader. Appl Environ Microbiol (1997) 0.75
Inhibition of intratracheal lung cancer development by systemic delivery of E1A. Oncogene (1996) 0.75
Potentiation of 2,6-dinitrotoluene genotoxicity in Fischer-344 rats by pretreatment with Aroclor 1254. Toxicology (1993) 0.75
Metabolism of 1-nitropyrene by human, rat, and mouse intestinal flora: mutagenicity of isolated metabolites by direct analysis of HPLC fractions with a microsuspension reverse mutation assay. J Toxicol Environ Health (1990) 0.75
Comparative gastrointestinal enzyme activity and activation of the promutagen 2,6-dinitrotoluene in male CD-1 mice and male Fischer 344 rats. Cancer Lett (1990) 0.75
Cardiomyocyte growth regulation by Ca(2+)-calmodulin. Trends Cardiovasc Med (2011) 0.75
A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcers after successful endoscopic therapy. Gastrointest Endosc (1999) 0.75